David Vaux Independent Chairman
David's early career was in law with Freehills (1981-83), investment banking with Macquarie (1985-87) and venture and development capital with the AFP / Patrick's group (1987-1997).
David was Executive Chairman and Managing Director of DCA Group Ltd (1998-2008). Under his leadership, DCA started diagnostic imaging (I-Med) and residential aged care (Amity) businesses. I-Med and Amity grew to be market leaders in Australasia. David has enjoyed extensive public and private company board roles through his career.
David was an original director of the Cardiology Network and was a director of many of the local practice groups that form the basis of GenesisCare.
Dan Collins, Founder and Managing Director
Dan's passion for healthcare was sparked after supporting his father's challenging patient journey and subsequent death from a complex disease known as amyloidosis. The experienced business analyst was driven to assess the challenges and opportunities to improve the healthcare system. Dan discovered a lack of coordination, wastage and poor patient access, and set out to transform healthcare outcomes for Australia's biggest killers: cancer and cardiovascular disease.
Dan has led GenesisCare from a single cardiology clinic in Brisbane with seven doctors in 2005, to become a global healthcare leader with more than 2500 employees across three countries and more than 100 clinic locations. After setting up what has now become Europe's largest private cancer service, Dan is now spearheading the company's expansion into China and Asia, and also positioning GenesisCare to co-develop and roll-out new treatment technologies and novel therapies.
With GenesisCare now leading or participating in more than 100 clinical trials, Dan has recently set up the GenesisCare Foundation - a not for profit charity focused on two main goals: better supporting clinical research in cancer and heart disease, and helping patients and their families access essential care.
Prior to founding GenesisCare, Dan managed business development initiatives for listed healthcare company, DCA Group Ltd. He was involved with public market investor relations for DCA Group Ltd, several major re-capitalisations, and a privatisation of the company building on his previous roles in capital markets andmanagement consulting. Dan holds a Bachelors of Commerce/Economics (BCom/BEcon) from The University of Queensland.
Dr Michael Guiney Oncologist Director
Dr Michael Guiney graduated in medicine from Melbourne University in 1979. He obtained a Fellowship of the Royal Australian College of Physicians in Medical Oncology in 1986 and a Fellowship of the Royal Australian and New Zealand College of Radiology in Radiation Oncology in 1989 while working at the Peter MacCallum Cancer Institute.
Michael was Unit Head of the Gastro-Intestinal Unit at Peter MacCallum from 1992 to 1998. He has been the Consultant Radiation Oncologist to St Vincent's Hospital Melbourne since 1999.
Michael has served on the Faculty of Radiation Oncology Board and Faculty sub-committees. He is a current member of the Australian Association of Private Radiation Oncology Practices. He has over 20 years' experience in private radiation oncology and was an original partner in Radiation Oncology Victoria where he is the Managing Partner.
Simon McGrath Non-Executive Independent Director
Simon McGrath joined the Board of GenesisCare in March 2013. Simon is currently Chief Operating Officer and an Executive Director of AAPC Limited (Accor Hotels Asia Pacific).
Simon has an extensive and highly respected career in the hotel sector, having worked in management positions domestically and overseas.
He has worked in senior executive positions in Australia's major city and tourist destinations, including Sydney, Gold Coast, Cairns, Hamilton Island and Ayers Rock Resort as well as internationally in Malaysia and Thailand.
Chen Ying is Chief Strategy Officer and member of the Executive Committee of China Resources, and the General Manager of China Resources' Strategy Management Department.
Mr Chen is a non-executive director of China Resources Cement Holdings Limited, China Resources Gas Group Limited, China Resources Power Holdings Company Limited, China Resources Land Limited (all listed on the Main Board of the Stock Exchange of Hong Kong Limited) and China Vanke Co. Ltd. (listed on the Main Board of the Stock Exchange of Hong Kong Limited and the Shenzhen Stock Exchange).
Mr Chen was previously the Managing Director of China Resources Land (Beijing) Limited and a Director of China Resources Land Limited and has held a number of board positions on other companies.
Mr Chen obtained a Bachelor's degree of Architectural Management from Tsinghua University and an MBA from the University of Oxford.
Kerry Zhang joined China Resources in March 2011 as Deputy General Manager of the Strategy Management Department of China Resources (Holdings) Limited. She leads the company's internationalisation strategy, as well as the company's real estate, pharmaceutical and healthcare businesses.
Ms Zhang has over 20 years' experience in corporate finance and strategy. Ms Zhang spent 10 years with Valspar Corporation, where she held a number of senior positions including Director of Global Strategy and CFO of Valspar Asia Pacific. Prior to that, she held marketing, sales and management roles at Reckitt Benckiser from 2000 to 2002 and at PepsiCo from 1995 to 2000.
Ms Zhang is a DBA candidate at Hong Kong Polytechnic University. She holds an MBA from Sasin-Kellogg Business School in Thailand, and a BS degree in Physics from Zhongshan University of China.
Zhou (Jason) Yi
Zhou (Jason) Yi started his career as a cardiovascular surgeon in 1993 in Anzhen Hospital (Beijing), one of the most respected cardiovascular medical centres in China.
After several years in medicine, Mr Zhou transitioned to a range of business management, pharmaceutical sales, marketing and medical consultancy roles for major global pharmaceuticals businesses before joining China Resources as the business director of healthcare industry in the Strategy Management Department in 2012.
Mr Zhou holds a Bachelor's degree of Clinical Medicine from Beijing Medical University (now merged to be the healthcare science school of Peking University), and an MBA in Finance by Chinese University of Hong Kong.
Cameron Brownjohn heads Macquarie Capital’s Principal Investment division in Australia and New Zealand. He has 19 years of experience in the financial services industry across Australia, Asia, Europe and the United States.
His experience spans investing, capital raising, mergers & acquisitions and general corporate finance advice across a broad range of sectors, including healthcare, general industrials, financial institutions, infrastructure, media, real estate, resources and telecommunications.
Cameron holds bachelors degrees in Law & Commerce with First Class Honours from the University of Queensland.
In addition to serving on various other Macquarie Group investee company boards, Cameron serves as Chairman of Special Olympics Australia.
Dr David O’Donnell Cardiologist Director
Dr David O’Donnell is a founding partner and the Chairman of Heart Care Victoria. David graduated from the University of Melbourne in 1993 and trained as a Cardiologist in Melbourne before undertaking a fellowship at Freeman Hospital, Newcastle Upon Tyne, England. He returned to Melbourne in 2002 working at Austin Health as an Interventional Electrophysiologist, becoming Director of Electrophysiology in 2012.
David’s hospital career has focused on the newer techniques for ablation of atrial fibrillation and ventricular tachycardia. In recent years his clinical and research emphasis has been in the device management of heart failure, pioneering a number of novel techniques for cardiac resynchronization. As a previous high performance athlete he has maintained a close involvement with elite athletes with heart conditions and has affiliations with a number of sporting clubs and organizations.
David has a passion for education and frequently lectures, educates and performs surgery around the world.
David joined the Board of GenesisCare in January 2016.